Watson Pharmaceuticals (WPI)

Profile

Exchange: NYSE       Sector: Healthcare       Industry: Drugs - Generic

Watson Pharmaceuticals, Inc. is a leading integrated global pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of generic, brand and biologic pharmaceutical products. It is the 5th largest pharmaceutical company in the United States based on number of prescriptions dispensed. It operates and manages its business as three operating segments: Global Generics, Global Brands and Anda Distribution. Its largest commercial market is the United States, followed by its key international markets including Western Europe, Canada, Asia/Pacific, South America and South Africa. Based in Parsippany, New Jersey, Watson's Generics division markets over 150 pharmaceutical product families, including oral contraceptives, the generic version of the opiate narcotic pain medication Vicodin, as well as Hydrocodone Bitartrate/APAP tablets. Watson's Brand division markets over 20 pharmaceutical product families for the treatment of various ailments. Its Anda Distribution Division distributes products for over 200 suppliers and is focused on providing next-day delivery and responsive service to its customers. The company was founded by Allen Y. Chao and David C. Hsia in 1984.